-
Amgen to expand its area roots with major investment
19 Sep 2025 00:37 GMT
… significant this investment by Amgen will be for Ventura … annual comprehensive financial report.
Amgen’s announcement follows other … will remain central to Amgen’s future.
Ventura County … opportunity, and world-class biotechnology.”
According to City Manager …
-
U.S. Biotechnology Market to Soar from USD 621.8 Billion in 2024 to USD 2004.86 Billion by 2034, Reports Towards Healthcare
17 Sep 2025 13:00 GMT
… across the biotechnology sector. Access the global biotechnology market size, … Johnson Services, Inc.
Abbott Laboratories
Amgen Inc.
Gilead Sciences, Inc.
… among pharmaceutical and biotechnology companies. The global biotechnology & pharmaceutical …
-
William Blair Reiterates a Buy on Amgen Inc (AMGN)
07 Sep 2025 15:09 GMT
… reiterated a Buy rating on Amgen Inc. (NASDAQ:AMGN) without disclosing any price … addition, the broader portfolio of Amgen Inc. (NASDAQ:AMGN) remains strong, and Phipps … long-term growth. Amgen Inc. (NASDAQ:AMGN) is a biotechnology company that discovers and …
-
Amgen investing $600 million in Thousand Oaks headquarters expansion
15 Sep 2025 21:23 GMT
Amgen, a Thousand Oaks-based biotechnology giant, plans to invest $ … health,” said Robert Bradway, Amgen chairman and chief executive officer … in recent weeks.
Besides Amgen, Newsom also that Gilead … as a leader in biotechnology, according to Newsom.
-
Global biotech leaders Amgen and Gilead announcing expansions in California, the #1 state for life sciences
15 Sep 2025 18:33 GMT
Earlier this month, biotechnology leader Amgen announced a $600 million investment … role as a leader in biotechnology.
California dominates in life sciences …
-
Amgen & Kyowa Kirin announce positive results from rocatinlimab phase 3 ASCEND study in adults with moderate to severe atopic dermatitis
10 Sep 2025 07:32 GMT
… research and development at Amgen. "These findings … terms of the agreement, Amgen leads the development, manufacturing, … including Europe and Asia.
Amgen discovers, develops, manufactures and … in drug discovery and biotechnology innovation for more than …
-
Amgen and Kyowa Kirin Announce Top-Line Results From Rocatinlimab Phase 3 ASCEND Long-Term Extension Study in Adults With Moderate to Severe Atopic Dermatitis
09 Sep 2025 04:12 GMT
… 2025 (GLOBE NEWSWIRE) -- Amgen (NASDAQ:AMGN) and Kyowa Kirin Co., … regulatory authority. About Amgen
Amgen discovers, develops, manufactures … ago, Amgen helped to establish the biotechnology industry and … drug discovery and biotechnology innovation for more …
-
AMGEN AND KYOWA KIRIN ANNOUNCE TOP-LINE RESULTS FROM ROCATINLIMAB PHASE 3 ASCEND LONG-TERM EXTENSION STUDY IN ADULTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS
09 Sep 2025 02:56 GMT
… /PRNewswire/ — Amgen (NASDAQ: AMGN) and Kyowa Kirin Co., Ltd … regulatory authority.
About Amgen
Amgen discovers, develops, manufactures … ago, Amgen helped to establish the biotechnology industry … drug discovery and biotechnology innovation for more …
-
aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635
05 Sep 2025 18:00 GMT
… Clinical Development at Aptevo Therapeutics (Nasdaq: APVO), during which she led … of Merck Research Laboratories and Amgen (Nasdaq: AMGN). BriaCell also announces that its … is an immuno-oncology focused biotechnology company developing targeted and effective …
-
Amgen to Invest Over $600 Million in New Science and Innovation Center at U.S. Headquarters
05 Sep 2025 16:40 GMT
… toward driving breakthroughs in biotechnology.
This investment reflects Amgen’s strong commitment … excellence.
Robert A. Bradway, Amgen’s chairman and CEO, emphasized … Angeles region.
This announcement follows Amgen’s recent investments, including …
About
© 1995-2025